Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study
Thursday, 16 May 2024
Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable short-term safety profile as compared to those reported with mRNA vaccines but adolescent females and those with a history of allergy were at a 1.6 times and three times increased risk of AEFI after taking Covaxin.
Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable short-term safety profile as compared to those reported with mRNA vaccines but adolescent females and those with a history of allergy were at a 1.6 times and three times increased risk of AEFI after taking Covaxin.
|
||||
|
||||
You Might Like💡 newsR Knowledge: Other News MentionsCOVID-19 Contagious disease caused by SARS-CoV-2NHS was within 'six or seven hours' of running out of PPE, says HancockSome hospitals in England were within "six or seven hours" of running out of personal protective equipment in the early stages of the COVID pandemic, a former..Sky News Eva Longoria Reveals She and Her Family Have Moved Out of the United States | THR News Video Credit: The Hollywood Reporter Duration: 01:15Published Karnataka cabinet OKs SIT probe into ‘BJP-era Covid scam’The Karnataka government has formed a special investigation team (SIT) to probe alleged financial irregularities during the previous BJP government's handling of..IndiaTimes Dominica to bestow its highest civilian award upon PM ModiPrime Minister Narendra Modi is set to receive the Dominica Award of Honour, Dominica's highest civilian award. The award recognizes PM Modi's contributions to..IndiaTimes |